22 Jun CPhI 9-11 October 2018 Madrid, Spain
Pharmazac participates in CPhI 2018.
Author: nstefanid
21 May Pharmazac launched the new product Petasitis Hybridus (Petagran)
Pharmazac has developed in its laboratories and launched in the Greek pharmaceutical market a nutraceutical, the titrate extract of Petasitis Hybridus in liquid hard gelatin capsules of 70,4 mg P A free, under the trade name Petagran. Petagran / Petasitis hybridus is effective in reducing the...
21 May Pharmazac launched the new product Etrozac / etoricoxib.
Pharmazac launched Etrozac / etoricoxib a selective cyclo-oxygenase – 2 (COX-2) inhibitor. Etrozac indicated for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain and the pain sings of inflammation associated with acute gouty arthritis....
21 May Pharmazac launched the new product Quental/quetiapine
Pharmazac launched the new product Quental/quetiapine 50,200,300 and 400mg in prolonged release tablets for the treatment of schizophrenia and bipolar disorders....
25 Apr 10th Panhellenic Conference of the Hellenic Society of Headache, Athens 15-17 March 2018
Pharmazac a Member of the Hellenic Association of Pharmaceutical Companies, announces the completion of the successful Conference of the Hellenic Society of Headache, that took place on 15 - 17 of March 2018 at the Museum of Cycladic Art in Athens.29 Mar Member of Hellenic Association of Pharmaceutical Companies
Since February 14, 2018 our company is a regular member Hellenic Association of Pharmaceutical Companies...
11 Dec Pharmazac announces Nitastin
Pharmazac has released the new product Nitastin 20mg film coated tablet for treatment of heart disease In addition to the hypolipidemic actions Nitastin has beneficial effects in endothelial dysfunction, on the vascular wall, the state of atheroma, improves blood rheology, have antioxidant, antiproliferative properties. There is evidence that...
24 Oct Pharmazac announces Rasagiline generic
Pharmazac has released the new product Ractilen (rasagiline tabs 1mg/tab ) for the treatment of PD...
17 Oct Pharmazac announces Calcium Folinate
Pharmazac has released the new product Calcium Folinate, an injectable solution 200mg/20ml Bt x 1 vial x20ml for intravenous or intramuscular use. Calcium Folinate / Pharmazac is the only available generic product in the Greek market....